IntegraGen S.A.
ALINT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €3,806 | €5,912 | €8,020 | €7,334 |
| - Cash | €1,900 | €1,834 | €2,460 | €2,936 |
| + Debt | €643 | €1,125 | €1,672 | €1,953 |
| Enterprise Value | €2,549 | €5,202 | €7,232 | €6,350 |
| Revenue | €8,698 | €12,537 | €13,167 | €11,324 |
| % Growth | -30.6% | -4.8% | 16.3% | – |
| Gross Profit | €1,786 | -€7 | -€6 | €44 |
| % Margin | 20.5% | -0.1% | -0% | 0.4% |
| EBITDA | -€296 | -€53 | €70 | €96 |
| % Margin | -3.4% | -0.4% | 0.5% | 0.9% |
| Net Income | -€256 | -€171 | -€4 | €15 |
| % Margin | -2.9% | -1.4% | -0% | 0.1% |
| EPS Diluted | -0.038 | -0.026 | -0.001 | 0.002 |
| % Growth | -46.7% | -5,080% | -121.7% | – |
| Operating Cash Flow | €0 | €0 | €403 | €412 |
| Capital Expenditures | €0 | €0 | €0 | €0 |
| Free Cash Flow | €0 | €0 | €403 | €412 |